top of page

Management team

Tom Collings, Kalium Health

Tom Collings
Chief Executive Officer

linkedin.png

Experienced team builder and leader of large, complex medical device development programs. Over 15 years specialising in medical technology and healthcare

Fiona Karet, Kalium Health

Fiona Karet PhD FRCP FMedSci
Chief Medical Officer

linkedin.png

Extensive experience of patient management and research and strong links with renal patient groups. Professor of Nephrology, University of Cambridge and Consultant in Renal Medicine at Addenbrooke's Hospital

Tanya Hutter, Kalium Health

Tanya Hutter PhD
Chief Technology Officer

linkedin.png

Medical sensor expert, inventor of multiple patents, co-founder of SensorHut, Director of Women Ahead of Their Time. Assistant Professor at The University of Texas at Austin

Liz Norgett, Kalium Health

Liz Norgett PhD
Chief Scientific Officer

linkedin.png

Expert in potassium disorders and skilled scientist with particular expertise in surface sensing chemistry and electrochemistry. Previous role as a Research Associate at The University of Cambridge

Board of Directors

Ken Galbraith, Kalium Health

Ken Galbraith
Chair of the Board

linkedin.png

Experienced biotechnology entrepreneur with almost 35 years of experience as an executive, director, investor and advisor in the North American and European medtech and biotechnology industry

Amanda Wooding, Kalium Health

Amanda Wooding
Director

linkedin.png

Life sciences focused developer of businesses. Deputy Head of Life Sciences at Cambridge Enterprise specialising in commercialising technology and creating companies

Caroline%20Savage%2C%20Kalium%20Health_e

Caroline Savage
Director (Kidney Research UK)

linkedin.png

Trustee of Kidney Research UK and former Chair of Nephrology at University of Birmingham. Former VP and Head of the early development Experimental Medicine unit at GSK

Mike Murphy, Kalium Health

Mike Murphy
Board Observer

linkedin.png

Portfolio Manager of Meltwind Advisory LLP, a company founded by Jonathan Milner to help manage his investments in early stage healthcare and biotech companies

bottom of page